IVI and Kazakhstan


IVI Member State

On October 28, 1996, Permanent Representative of Kazakhstan to the United Nations, Ambassador Akmaral Kh. Arystanbekova, signed the IVI Establishment Agreement.


Supporting Independent Immunization and Vaccine Advisory Committees Initiative (SIVAC)

From 2010 to 2013, IVI provided technical assistance to the governments of Mongolia, Kazakhstan, and Kyrgyzstan with the establishment of National Immunization Technical Advisory Groups (NITAGs). IVI and the Kazakhstan Ministry of health began planning the Kazakh NITAG in 2010. In 2011, the SIVAC Initiative co-organized several workshops in Kazakhstan, Belarus, and Bhutan in collaboration with WHO regional offices and the U.S. CDC.

Kazakhstan launched its NITAG in 2012, while IVI continued providing support and technical assistance through 2013.


Tuberculosis (TB) Vaccine Program

With funding from Sida, in 2010 IVI evaluated the effectiveness of Kazakhstan’s BCG vaccination program and studied the seasonal variations of TB incidence in Kazakhstan. The study was a retrospective birth cohort study comparing three different groups within the national TB vaccination database in Almaty. The study indicated that BCG vaccines manufactured in Japan were more effective than the BCG vaccines produced in Serbia, which were also more effective than Russian-produced BCG vaccines.